Talinolol

DB11770InvestigationalSmall molecule

Talinolol has been investigated for the basic science of Gastrointestinal Motility Disorder.

Chemical structure of Talinolol
Mechanism
Curator reviewed
Formula / weight
C20H33N3O3 · 363.4943 g/mol (avg)

Resolves to

Compound
UNII3S82268BKGCAS57460-41-0ChEMBLCHEMBL152067ChEBI135533PubChem68770
Clinical / RWD
RxNorm37546ATCC07AB13
Structure
InChIKeyMXFWWQICDIZSOA-UHFFFAOYSA-NSMILESCC(C)(C)NCC(O)COC1=CC=C(NC(=O)NC2CCCCC2)C=C1
Targets
P08588ADRB1
Transporters
P08183ABCB1P46721SLCO1A2Q92887ABCC2

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3TransportersSubstrate / inhibitor direction, not just membership
Listed above
1,602Drug interactionsStructured to mechanism, not free text
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 19 drug categories
Sign in
15+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Talinolol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In